Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor

Journal of Medicinal Chemistry

Volumn 46, Issue 8, 2003, Pages 1289-1292

  Schmidt, Jonathan M ^a   Tremblay, Gilles B ^a   Pagé, Martine ^a   Mercure, Julie ^a   Feher, Miklos ^a   Dunn Dufault, Robert ^a   Peter, Markus G ^a   Redden, Peter R ^a  

^a Signalgene Inc Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; ALTERNARIOL; ANTIMITOTIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CYTOSTATIC AGENT; DIBENZO[B,D]PYRAN 6 ONE; ELLAGIC ACID; ESTROGEN RECEPTOR; GILVOCARCIN V; INDAN DERIVATIVE; INDANOCENE; SEMAXANIB; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CYTOSTASIS; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MITOSIS INHIBITION;

ANGIOGENESIS INHIBITORS; BINDING, COMPETITIVE; CELL DIVISION; COMPUTER SIMULATION; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HUMANS; MODELS, MOLECULAR; PYRANS; RECEPTORS, ESTROGEN; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED; UMBILICAL VEINS;

EID: 0242585425     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm034007d     Document Type: Article

References (35)

1. Fantl, W. J.; Rosenberg, S. In Annual Reports in Medicinal Chemistry; Doherty, A. M., Ed.; Academic Press: San Diego, CA, 2000; Vol. 35, pp 123-133.
2. Matter, A. Tumor angiogenesis as a therapeutic target. Drug Discovery Today 2001, 6, 1005-1024.
3. Fotsis, T.; Zhang, Y.; Pepper, M. S.; Adlercreutz, H.; Montesano, R.; Nawroth, P. P.; Schweigerer, L. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesis and suppresses tumor growth. Nature 1994, 368, 237-239.
4. Folkman, J.; Watson, K.; Ingber, D. E.; Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989, 339, 58-61.
5. Schumacher, G.; Kataoka, M.; Roth, J. A.; Mukhopadhyay, T. Potent antitumor activity of 2-methoxyestradiol in human pancreatic cancer cell lines. Clin. Cancer Res. 1999, 5, 493-499.
6. Wassberg, E. Angiostatic treatment of neuroblastoma. Upsala J. Med. Sci. 1999, 104, 1-24.
7. Blood, C. H.; Zetter, B. R. Tumor interaction with the vasculature: Angiogenesis and tumor metastasis. Biochim. Biophys. Acta 1990, 1032, 89-118.
8. Klauber, N.; Parangi, S.; Flynn, E.; Hamel, E.; D'Amato, R. J. Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol. Cancer Res. 1997, 57, 81-86.
9. Yue, T. L.; Wang, X. K.; Louden, C. S.; Gupta, S.; Pillarisetti, K.; Gu, J. L.; Hart, T. K.; Lysko, P. G.; Feuerstein, G. Z. 2-Methoxyestradiol, an endogenous metabolite, induces apoptosis in endothelial cells and inhibits angiogenesis: Possible role for stress-activated protein kinase signaling pathway and fas expression. Mol. Pharmacol. 1997, 51, 951-962.
10. Tsukamoto, A.; Kaneko, Y.; Toshida, T.; Han, K.; Ichinose, M.; Kimura, S. 2-Methoxyestradiol, an endogenous metabolite of estrogen enhances apoptosis and β-galactosidase expression in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1998, 248, 9-12.
11. Josefsson, E.; Tarkowski, A. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum. 1997, 40, 154-163.
12. Reiser, F.; Way, D.; Bernas, M.; Witte, M.; Witte, C. Inhibition of normal and experimental endothelial cell proliferation and cell cycle progression by 2-methoxyestradiol. Proc. Soc. Exp. Biol. Med. 1998, 219, 211-216.
13. 2-Methoxyestradiol: A Novel Endogenous and Anti-Angiogenic Agent; Pribula, V. S., LaVallee, T. M., Green, S. J., Eds.; Humana Press, Inc.: Totowa, NJ, 2002.
14. Squillace, D. P.; Reid, J. M.; Kuffel, M. J.; Ames, M. M. Bioavailability and in vivo metabolism of 2-methoxyestradiol in mice. Proc. Am. Assoc. Cancer Res. 1998, 39, 523.
15. Alo, B. I.; Kandil, A.; Patil, P. A.; Sharp, M. J.; Siddiqui, M. A.; Snieckus, V. Sequential directed ortho metalation - boronic acid cross-coupling reactions. A general regiospecific route to oxygenated dibenzo[b, d]pyran-6-ones related to ellagic acid. J. Org. Chem. 1991, 56, 3763.
16. Langer, P.; Saleh, N. N. R.; Freifeld, I. Efficient synthesis of biaryl lactones by domino retro-Michael-aldol lactonization reactions. Chem. Commun. 2002, 2, 168-169.
17. Weidner-Wells, M. A.; Altom, J.; Fernandez, J.; Fraga-Spano, S. A.; Hilliard, J.; Ohemeng, K.; Barret, J. F. DNA gyrase inhibitory activity of ellagic acid derivatives. Bioorg. Med. Chem. Lett. 1998, 8, 97-100.
18. Edwards, J. P.; West, S. J.; Marschke, K. B.; Mais, D. E.; Gottardis, M. M.; Jones, T. K. 5-Aryl-1,2-dihydro-5H-chromeno-[3,4-f]quinolines as potent, orally active, non-steroidal progesterone receptor antagonists. The effect of D-ring substituents. J. Med. Chem. 1998, 41, 303.
19. McGee, L. R.; Confalone, P. N. On the photobiology of the Gilvocarcins. Total synthesis of Defucogilvocarcin V and a related photoactive vinyl phenol. J. Org. Chem. 1988, 53, 3695.
20. Adapted from the following. Teicher, B. A.; Alvarez, E.; Menon, K.; Esterman, M. A.; Considine, E.; Shih, C.; Faul, M. M. Antiangiogenic effects of a protein kinase Cbeta-selective small molecule. Cancer Chemother. Pharmacol. 2002, 49, 69-77.
21. Tremblay, G. B.; Pagé, M.; Peter, M.; Feher, M.; Dunn-Dufault, R.; Redden, P.; Mercure, J.; Schmidt, J. M. Unpublished results.
22. LaVallee, T. M.; Zhan, X. H.; Herbstritt, C. J.; Kough, E. C.; Green, S. J.; Pribluda, V. S. 2-Methoxyestradiol inhibits proliferation and induces apoptosis independently of estrogen receptors alpha and beta. Cancer Res. 2002, 62, 3691-3697.
23. D'Amato, R. J.; Lin, C. M.; Flynn, E.; Folkman, J.; Hamel, E. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3964-3968.
24. Mukhopadhyay, T.; Roth, J. A. Induction of apoptosis in human lung cancer cells after wild-type p53 activation by methoxyestradiol. Oncogene 1997, 14, 379-384.
25. Seegers, J. C.; Lottering, M. L.; Grobler, C. J.; van Papendorp, D. H.; Habbersett, R. C.; Shou, Y.; Lehnert, B. E. The mammalian metabolite, 2-methoxyestradiol, affects p53 levels and apoptosis induction in transformed cells but not in normal cells. J. Steroid Biochem. Mol. Biol. 1997, 62, 253-267.
26. Lin, H. L.; Liu, T. Y.; Wu, C. W.; Chi, C. W. 2-Methoxyestradiol-induced caspase-3 activation and apoptosis occurs through G(2)/M arrest dependent and independent pathways in gastric carcinoma cells. Cancer 2001, 92, 500-509.
27. Huang, P.; Feng, L.; Oldman, E. A.; Keating, M. J.; Plunkett, W. Superoxide dismutase as a target for the selective killing of cancer cells. Nature 2000, 407, 390-395.
28. Pribluba, V. S.; Gubish, E. R., Jr.; LaVallee, T. M.; Treston, A.; Swartz, G. M.; Green, S. J. 2-Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate. Cancer Metastatis Rev. 2000, 19, 173-179.
29. Tremblay, G. B.; Pagé, M. Unpublished results.
30. Feher, M.; Schmidt, J. M. Multiple flexible alignment with SEAL: a study of molecules acting on the colchicine binding site. J. Chem. Inf. Comput. Sci. 2000, 40, 495-502.
31. Feher, M.; Schmidt, J. M. Identifying potential binding modes and explaining partitioning behavior using flexible alignments and multidimensional scaling. J. Comput.-Aided Mol. Des. 2001, 15, 1065-1083.
32. Jones, G.; Wilett, P.; Glen, R. C.; Leach, A. R.; Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 1997, 267, 727-748.
33. Fraley, M. E.; Antanavage, J.; Arrington, K. L.; Ciecko, P. A.; Coll, K. E.; Gibbs, J. B.; Hambaugh, S. R.; Hartman, G. D.; Heimbrook, D. C.; Hoffman, W. F.; Hungate, R. W.; Kohl, N. E.; Mao, X.; McFall, R. C.; Rands, E.; Rickert, K.; Sepp-Lorenzino, L.; Shipman, J. M.; Tebben, A. J.; Thomas, K. A. Discovery, synthesis, SAR and in vitro/in vivo characterization of a novel quinolinone class of VEGFR-2 (KDR) kinase inhibitors. Abstracts of Papers. 224th National Meeting of the American Chemical Society, Boston, MA, 2002; American Chemical Society: Washington, DC, 2003; MEDI 221.
34. Berman, H. M.; Westbrook, J.; Feng, Z.; Gilliland, G.; Bhat, T. N.; Weissig, H.; Shindyalov, I. N.; Bourne, P. E. The Protein Data Bank. Nucleic Acids Res. 2000, 28, 235-242.
35. Pribluda, V. S.; LaVallee, T. M.; Green, S. J. In The New Angiotherapy; Fan, T.-P. D., Kohn, E. C., Eds.; Humana Press: Totowa, NJ, 2002; pp 387-407.